MedCity News March 24, 2025
Frank Vinluan

A month before 23andMe’s bankruptcy filing, CEO Anne Wojcicki had a fully financed proposal to take the genetic testing company private. The financing fell apart, and a series of alternative proposals by Wojcicki did not result in a deal.

23andMe CEO Anne Wojcicki has been trying to take the DNA testing company private this past year, making clear along the way that she would oppose any deal to sell the business to someone else. Wojcicki later softened her opposition, but that didn’t stop her from trying to buy the company she co-founded. A flurry of new proposals from Wojcicki over the past month failed to win over the company’s board of directors. Now 23andMe is preparing to sell its assets...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma / Biotech
Podcast: Perspectives and projections on the 2025 biotech landscape
Makary’s FDA Has Options In Industry Fight Over Weight Loss Drugs
Collective Health, Noom Health partner for weight management
Faster Cancer Drug Approvals Tied to Clinical Benefits
Skepticism Hangs Over Cancer Drugs Stuck With Accelerated Approval for Years

Share This Article